Results 221 to 230 of about 106,309 (302)
ABSTRACT Cirrhosis is a global health concern, with ascites being the most prevalent decompensating event. Intravenous (IV) human albumin (HA) is administered during large‐volume paracentesis (LVP) to prevent complications. The standard (6–8 g HA/L ascites) is empirically chosen, potentially leading to overtreatment and added costs.
Kimberly K. I. M. Bot +3 more
wiley +1 more source
Short- and Long-Term Outcomes of Radiofrequency Ablation for Early Hepatocellular Carcinoma with Liver Dysfunction. [PDF]
Xiao S +8 more
europepmc +1 more source
Argon Plasma Coagulation as Rescue Endoscopic Hemostasis for Acute Variceal Bleeding in Cirrhosis: A Retrospective Cohort Comparison with Band Ligation. [PDF]
Ciorba IM +2 more
europepmc +1 more source
ABSTRACT Background Portal vein thrombosis (PVT) is a common sequela of cirrhosis. Despite regression of fibrosis/cirrhosis observed among some patients after disease‐specific treatment, few studies have considered the role of treatment and response on risk of PVT among patients with cirrhosis across different liver disease states.
Humberto C. Gonzalez +10 more
wiley +1 more source
Proteomic Trajectories of Metabolic and Proteostatic Adaptation During Normothermic Liver Perfusion
ABSTRACT Background Normothermic machine perfusion (NMP) enables metabolic restoration and viability testing of liver grafts, but current viability criteria incompletely predict post‐transplant outcomes. The molecular basis of graft resilience or biliary vulnerability remains unclear. This study aimed to characterise tissue‐level proteomic trajectories
Heithem Jeddou +10 more
wiley +1 more source
Quantifying Epistemic Uncertainty in Multimodal Long-Tailed Classification: A Belief Entropy-Based Evidential Fusion Framework. [PDF]
Zhu G.
europepmc +1 more source
ABSTRACT Background & Aims To develop and validate a CT‐based radiomics model to assess HVPG and predict a composite endpoint of liver‐related events (LRE: decompensation and liver‐related death) in patients with cirrhosis. Methods This retrospective study included 357 cirrhosis patients, who received invasive HVPG measurements, 120 liver‐healthy ...
Celine Sin +13 more
wiley +1 more source
DOACs reduce risk for new-onset portal hypertension in patients with cirrhosis and atrial fibrillation: A retrospective cohort study. [PDF]
Su Y, Wang J, Dong Q, Guan H, Ma C.
europepmc +1 more source
ABSTRACT Background and Aims Cirrhosis favours infections that can lead to liver decompensation and death. Some of these infections can be prevented by vaccination. This study aimed to evaluate the immune response after HBV, pneumococcal, diphtheria, and tetanus vaccination in cirrhotic patients.
Vincent Haghnejad +10 more
wiley +1 more source

